ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 143 filers reported holding ANI PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,959,866 | +55.1% | 68,203 | +43.8% | 0.25% | +73.8% |
Q2 2023 | $2,553,839 | +186.9% | 47,443 | +72.4% | 0.14% | +281.6% |
Q2 2020 | $890,000 | -21.2% | 27,526 | -0.7% | 0.04% | -39.7% |
Q1 2020 | $1,130,000 | -34.4% | 27,726 | -0.8% | 0.06% | +8.6% |
Q4 2019 | $1,723,000 | -17.5% | 27,943 | -2.5% | 0.06% | -22.7% |
Q3 2019 | $2,088,000 | -3.5% | 28,649 | +8.9% | 0.08% | +4.2% |
Q2 2019 | $2,163,000 | +9.9% | 26,314 | -5.7% | 0.07% | +14.3% |
Q1 2019 | $1,969,000 | +50.1% | 27,914 | -4.2% | 0.06% | +31.2% |
Q4 2018 | $1,312,000 | -11.4% | 29,139 | +11.3% | 0.05% | -9.4% |
Q3 2018 | $1,481,000 | -31.5% | 26,192 | -19.1% | 0.05% | -32.9% |
Q2 2018 | $2,163,000 | +34.8% | 32,378 | -0.1% | 0.08% | +1.3% |
Q1 2017 | $1,605,000 | -20.1% | 32,426 | -2.1% | 0.08% | -22.8% |
Q4 2016 | $2,008,000 | -9.2% | 33,126 | -0.6% | 0.10% | -12.9% |
Q3 2016 | $2,211,000 | – | 33,326 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MANGROVE PARTNERS IM, LLC | 326,778 | $20,152,000 | 2.95% |
Hawk Ridge Capital Management | 188,761 | $11,641,000 | 1.89% |
Global Alpha Capital Management Ltd. | 169,746 | $10,468,000 | 1.55% |
Mesirow Financial Investment Management, Inc. | 5,723 | $353,000 | 1.49% |
1492 Capital Management LLC | 25,093 | $1,547,000 | 1.37% |
THB ASSET MANAGEMENT | 91,018 | $5,613,000 | 1.04% |
Regent Investment Management LLC | 41,329 | $2,549,000 | 0.78% |
Phocas Financial Corp. | 101,567 | $6,263,000 | 0.75% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 284,334 | $17,535,000 | 0.75% |
HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $2,189,000 | 0.70% |